APR Applied Pharma Research s.a. of Switzerland launches its new corporate website and announces key strategic changes in its Business Model to better compete in the rapidly changing Healthcare industry 15 June 2010
MonoSol Rx Announces FDA Approval of Zuplenz Oral Soluble Film for Treatment of Nausea and Vomiting 9 June 2010
Nautilus Neurosciences Announces U.S. Launch of CAMBIA (Diclofenac Potassium for Oral Solution) for the Treatment of Migraine 8 June 2010
APR Applied Pharma Research s.a. (“APR”) and Labtec GmbH (“Labtec”) announce the European Approval of Ondansetron RapidFilm™ 23 March 2010
Linkedin